Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:EYCT
Date4/2014
Raised$102M
Post IPO Valuation

General Information

Offices

West Lafayette, USA
3000 Kent Avenue
Suite A1-100
West Lafayette, IN, 47906
USA

People

CFO
President & CEO
Board Member
Board Observer

Funding

TOTAL $41M
FUNDING TOTAL $41M
Series C, 1/2010
Sanderling Ventures
Burrill & Company
American Bailey Ventures
Blue Chip Venture Company
Triathlon Medical Venture Partners
$26M
Venture Round, 8/2010
MidCap Financial
Silicon Valley Bank
$15M
DEBT TOTAL $8.1M
Debt, 12/2010
$8.1M

Tags

Endocyte

Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug; BMS753493, a folate-targeted anti-cancer therapy drug; EC0434 to target folate receptor positive tumors; and EC0305, an anti-cancer therapy drug. It also offers EC0286, a folate-targeted small molecule for the treatment of inflammatory diseases; and EC20, a folate-targeted radiopharmaceutical imaging agent to identify folate-receptor positive cancers. The company was founded in 1996 and is based in West Lafayette, Indiana.

Recent Milestones

  • Stock
    Went public with stock symbol NASDAQ:EYCT. (4/7/14)
    Posted 4/8/14 at 7:49pm
  • Check
    Endocyte — Endocyte Changes IPO Terms For 2nd Time In 2 Days (2/4/11)
    Posted 2/4/11 at 5:36am via dowjones.com
  • Dollar
    Endocyte received $8.1M in Debt funding. (12/27/10)
    Posted 1/13/14 at 4:10am via sec.gov
  • Dollar
    Endocyte received $15M in Venture Round funding. (8/30/10)
    Posted 9/5/10 at 8:13pm via endocyte.com
  • Dollar
    Endocyte received $26M in Series C funding. (1/19/10)
    Posted 1/20/10 at 9:32pm via onbiovc.com
  • Check
    Endocyte added Ron Ellis as President & CEO.
    Posted 1/20/10 at 9:32pm
  • Check
    Endocyte added Mike A. Sherman as CFO.
    Posted 4/9/14 at 3:05am

Videos

Screenshots

Endocyte screenshot
Above: Home Page
Uploaded: 1/21/10

Stock Price

Sources

  1. Endocyte, Inc.: Series C $26M (onbiovc.com) [edit]
  2. Endocyte secures $15 million credit facility (endocyte.com) [edit]
  3. SEC (sec.gov) [edit]
  4. Endocyte Changes IPO Terms For 2nd Time In 2 Days (fis.dowjones.com) [edit]
Edit This Page
Last Edited 4/9/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy